Emilie Allard-Vannier

11PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyObstetrics and gynaecologyNanomaterialsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 05, 2025
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer.

Etienne Auvert, Emmanuel Douez, Louis Jolivet

|Jan 08, 2025
Metformin-encapsulating immunoliposomes conjugated with anti-TROP 2 antibody fragments for the active targeting of triple-negative breast cancer.

Daiva Vozgirdaite, Emilie Allard-Vannier, Florence Velge-Roussel

|Oct 22, 2024
Human ovarian extracellular vesicles proteome from polycystic ovary syndrome patients associate with follicular development alterations.

Noemie Couty, Anthony Estienne, Soazig Le Lay

|Dec 23, 2022
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines.

Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey

|Dec 23, 2022
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment.

Sahar Eljack, Stephanie David, Igor Chourpa

|Nov 26, 2022
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells.

Sahar Eljack, Emilie Allard-Vannier, Yoann Misericordia

Pageof 2

Frequent Collaborators

4 joint publications

Nicolas Aubrey

3 joint publications

Katel Hervé-Aubert

3 joint publications

Cyril Colas

3 joint publications

Nicolas Joubert